2 Vacaville officers released from hospital after suspected fentanyl exposure
The Vacaville Police Department said that the officers were responding to a call around 5 p.m. on Countrywood Circle when one of them began experiencing symptoms consistent with fentanyl exposure.
The second officer quickly administered Narcan, a nasal spray used to reverse opioid overdoses. Soon after giving the Narcan, the second officer also began exhibiting similar symptoms.
Both officers were taken to a nearby hospital for treatment and were later discharged.
Police said it's unclear when or how the exposure occurred, noting that the officers had responded to several calls together earlier in the day.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
12-year-old sworn in as honorary sheriff ahead of organ transplant
A 12-year-old New York boy who has kidney failure was sworn in as an honorary sheriff this week. Suffolk County Sheriff Errol D. Toulon Jr. oversaw the swearing-in ceremony of Wyatt Houppert on Tuesday, calling it an important event for everyone at the sheriff's office. "Welcoming Wyatt Houppert as 'Sheriff for the Day' was a meaningful moment for our agency," Toulon said in a statement to "Good Morning America." Son of sheriff's deputy sworn in on the same force as late father Wyatt's mom, Devan Houppert, told "GMA" they found out in 2021 that Wyatt was born with one regular kidney and another "the size of a walnut" that "had never developed." Houppert said doctors told them that over the years, Wyatt's one full-size kidney began to fail, and by February 2025, they learned both of Wyatt's kidneys had gone into failure, and he needed to be treated with hemodialysis and would eventually require a kidney transplant. According to the National Institute of Diabetes and Digestive and Kidney Diseases, hemodialysis is a treatment that helps the body filter water and waste from the bloodstream because the kidneys are unable to do so by themselves. Despite having to undergo dialysis three to four times a week for at least four hours per session, Houppert said her son has not lost hope and has kept a positive outlook for months. "Never for a second did he even consider it's not going to be OK," Houppert said. "It's always, 'We got this. Come on, let's just do it. Where's my kidney? Let's go right now.' And just so positive, just, 'It's going to be OK.'" "Many times, me and my husband have been upset sitting there, and then we're looking at him, going, 'Wait a second, we have so much to learn from this child,'" she added. "Because he's sitting there with the best attitude." Houppert said Dawn Rice, a family friend, volunteered to get evaluated to see if she could donate a kidney to Wyatt, and after testing, she said doctors surprised the family with the news that Rice was "a perfect match" for Wyatt. Rice also happens to be the wife and sister of two corrections officers with the Suffolk County Sheriff's Office, which honored her as well at Wyatt's "sheriff for the day" ceremony. "[Wyatt's] strength and courage are truly inspiring, and the selfless kidney donation by Dawn Rice reflects the compassion and unity of our Sheriff's Office family," Toulon said. 6-year-old with heart condition sworn in as honorary police officer Houppert said her 12-year-old was "over the moon" to be "sheriff for the day." "He's a very, like, stoic, serious guy. So when you get those smiles, and he's telling you, 'It's the best day ever,' you know that it really was," Houppert recalled. "He definitely took his sheriff duties very seriously all day," she added. "It was so funny hearing him telling his older brother, 'Turn the TV up. I'm the sheriff. We have to get pizza for dinner. I'm the sheriff.'" Wyatt is scheduled to undergo his kidney transplant at Hassenfeld Children's Hospital at NYU Langone in New York City on Monday. Dr. Marissa Lipton, a pediatric nephrologist in the Pediatric Kidney Transplant Program at Hassenfeld Children's Hospital, told "GMA" the kidney transplant will be life-changing for the boy. "Wyatt is an incredible kid with a wonderfully supportive family and community behind him. Our entire team at Hassenfeld Children's Hospital at NYU Langone is honored to care for him and support his family as he prepares for his transplant on Monday," Lipton said in an emailed statement. "We're looking forward to getting him off dialysis. This transplant will truly change his life, and we're so grateful to his living donor for this incredible gift," Lipton added. "We can't wait to see Wyatt back to playing outside and enjoying his video games like any active 12-year-old." Solve the daily Crossword
Yahoo
6 minutes ago
- Yahoo
Celcuity to Announce Topline Results for the PIK3CA Wild-Type Cohort from Phase 3 VIKTORIA-1 Trial in HR+/HER2- Advanced Breast Cancer
MINNEAPOLIS, July 25, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the Company will hold a conference call and webcast on Monday, July 28, 2025 at 8:00 AM ET to disclose the topline results of the PIK3CA Wild-Type Cohort from the Phase 3 VIKTORIA-1 trial. Webcast and Conference Call Information The Celcuity management team will host a webcast/conference call on Monday, July 28, 2025 at 8:00 a.m. ET to discuss the topline results from the Phase 3 VIKTORIA-1 trial. Those who would like to participate may access the live webcast here, or register in advance for the teleconference here. A replay of the webcast will be available on the Celcuity website following the live event. About Celcuity Celcuity is a clinical-stage biotechnology company pursuing development of targeted therapies for treatment of multiple solid tumor indications. The company's lead therapeutic candidate is gedatolisib, a potent, pan-PI3K and mTORC1/2 inhibitor that comprehensively blockades the PAM pathway. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3Kα, AKT, or mTORC1 alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients. A Phase 1/2 clinical trial, CELC-G-201, evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is ongoing. A Phase 3 clinical trial, VIKTORIA-2, evaluating gedatolisib plus a CDK4/6 inhibitor and fulvestrant as first-line treatment for patients with HR+/HER2- advanced breast cancer is currently enrolling patients. More detailed information about Celcuity's active clinical trials can be found at Celcuity is headquartered in Minneapolis. Further information about Celcuity can be found at Follow us on LinkedIn and X. View source version of release on Contacts: Celcuity Inc. Brian Sullivan, bsullivan@ Vicky Hahne, vhahne@ (763) 392-0123 ICR HealthcarePatti Bank, (415) 513-1284Sign in to access your portfolio
Entrepreneur
7 minutes ago
- Entrepreneur
Venus Williams Returns to Tennis to Keep Health Insurance
Tennis icon Venus Williams made more than $42 million during her professional career, but said this week that she needed to return to work to keep her insurance. Venus Williams, 45, hadn't played professional tennis in a year and a half. But she played in the Mubadala Citi DC Open in Washington, D.C. this week, and for a surprising reason. "I had to come back for the insurance," Williams said after winning the first round. (She lost in the second round on Thursday.) Related: Serena Williams Launches a New Company That She's Been Working on for 6 Years "They informed me this year that I'm on COBRA, so it's like, I got to get my benefits on," Williams added. The crowd laughed, but Williams appeared to be serious. Venus Williams after becoming the oldest WTA match winner since 2004: "I had to come back for the insurance, because they informed me this year that I'm on cobra. So it's like, I got to get my benefits on" ???? — The Tennis Letter (@TheTennisLetter) July 23, 2025 "I'm always at the doctor, so I need this insurance," she said. Williams has been open about her struggle with uterine fibroids, telling NBC News Now earlier this month that the condition has affected her for 30 years. MarketWatch reports that Women's Tennis Association (WTA) players are offered insurance plans that provide global coverage for the tour's extensive travel requirements, but athletes need to meet certain requirements to qualify. "Player members that are eligible for such access to health insurance must be inside the rankings of 500 in singles or 175 in doubles and have played a minimum of three WTA 250-level and above events, including Grand Slams, in the last year," a WTA spokesperson told MarketWatch. Related: Alexis Ohanian Says This Is His Best Investment So Far: $10,000 Turned Into More Than $17 Million This means we could see Williams on the professional court again soon. It's also raised many questions and comments, especially on Reddit, which was co-founded by Venus's brother-in-law, Alexis Ohanian, about the price of health care in the U.S. According to ESPN, Williams made more than $42 million playing professional tennis, during which she won 49 singles titles, including five Wimbledon and two U.S. Open Championships. Williams also won four Olympic gold medals. Join top CEOs, founders and operators at the Level Up conference to unlock strategies for scaling your business, boosting revenue and building sustainable success.
